Dementia risk 24% lower among people given common vaccine

Date:

Share this article:

Del denne artikel:

A major study of more than 500,000 older adults has found a striking link between the shingles vaccine and dementia risk.

For many families, concerns about dementia begin with small changes. A forgotten name or missed appointment may be harmless, but worries about cognitive decline often grow with age.

Researchers in the United States have now examined whether a vaccine developed for an entirely different condition could be associated with brain health. The findings were published in Annals of Internal Medicine and reported by ScienceDaily.

Not proof yet

The study focused on Shingrix, a vaccine used to prevent shingles. Researchers found that older adults who received at least one dose were less likely to have a dementia diagnosis recorded during four years of follow-up.

After statistical adjustments, vaccination was associated with a 24 percent lower risk of dementia.

Also read: Study makes major finding: Every extra hour of unbroken sitting raises cancer death risk by 10%

However, the researchers stressed that the study identified an association rather than proving that Shingrix itself was responsible for the difference.

Thousands followed

The analysis included 509,926 people aged 66 or older who entered US nursing or rehabilitation facilities between 2017 and 2022. None had a recorded dementia diagnosis at the beginning.

During follow-up, dementia was recorded in 18.8 percent of vaccinated participants, compared with 24.6 percent of those who had not received the vaccine.

Although researchers adjusted for differences between the groups, other factors could still have influenced the findings. Clinical trials would be needed before any preventive effect against dementia could be established.

Also read: If you take amlodipine or felodipine, you may need to avoid 4 foods

Funding disclosed

Kaley Hayes of Brown University led the research alongside scientists from institutions including the University of Delaware and Providence Veterans Affairs Medical Center.

GlaxoSmithKline, the manufacturer of Shingrix, funded the research. According to the researchers, the company had no control over the study design, analysis or decision to publish.

Also read: How pineapple can affect your body if you eat it every day

This article is made and published by Mie Hermansen, who may have used AI in the preparation.

Other articles

Feeling physically weaker or slower than before? Your heart may be sending a warning years early

A new look at thousands of older adults suggests the slowdown we blame on aging may mean something more.

More than half of young adults put their type 2 diabetes into remission without drugs

The plan behind it was tough, tightly supervised, and worked on patients clinicians often struggle to reach.

An AI learned to see a migraine coming the next day, from a signal clinicians often overlook

Built on nearly 800,000 diary days from people living with migraine, the forecast was far more accurate than many had expected.

The same workout may affect men’s and women’s livers differently

Researchers watched the same workout play out inside the body in two very different ways, depending on sex.

Feeling physically weaker or slower than before? Your heart may be sending a warning years early

A new look at thousands of older adults suggests the slowdown we blame on aging may mean something more.

More than half of young adults put their type 2 diabetes into remission without drugs

The plan behind it was tough, tightly supervised, and worked on patients clinicians often struggle to reach.

An AI learned to see a migraine coming the next day, from a signal clinicians often overlook

Built on nearly 800,000 diary days from people living with migraine, the forecast was far more accurate than many had expected.